Funding for the SynLeigh Project to Advance New Therapies for Leigh Syndrome IMP, Mitocon and Cure Mito Welcome ERDERA Funding International […]...

IMP Annual Meeting 30-31 May 2026, France IMP’s Annual Meeting will take place 30–31 May 2026 at Brit Hotel Acropole, […]...

Patients at the Heart of Research: IMP’s Role in the SIMPATHIC Drug Repurposing Project The SIMPATHIC project continues to make […]...

Rare Disease Day 28 Feb 2026 Rare Disease Day is a global campaign that highlights the 300 million people worldwide […]...

Amplifying Our Collective Voice: IMP at National and International Events As members of IMP, we are part of a global […]...

International MELAS Consensus Meeting in Pisa: A Milestone for Patient Advocacy and Research From 28 to 30 November this autumn, […]...

Mitochondrial Awareness Week 2025: 1.5million reached!! This September, our community united for World Mitochondrial Disease Week, a celebration of green lights, […]...

First patient with rare muscle disease treated with own stem cells 9 November 2025 Maastricht UMC+ has, for the first […]...

IMP Welcomes FDA Approval of First-Ever Treatment for TK2d International Mito Patient (IMP) is delighted to welcome yesterday’s approval by […]...

Watch our Webinar: The power of nutrition and mitochondrial diseases As part of LHON Awareness Day, we hosted a powerful […]...

Barth syndrome therapy sets precedent for future treatments targeting mitochondrial dysfunction In a landmark decision, the U.S. Food and Drug […]...

IMP Launches New TK2d Video To mark TK2d Awareness Day 2025, we’ve released a new video that amplifyies the voices […]...

IMP now has members across three continents We’re delighted to welcome three new members to IMP. With these new members, […]...

The birth of eight healthy babies in the UK through mitochondrial donation (also known as Mitochondrial Replacement Therapy) has been […]...

IMP is delighted to announce the results of its recent Board elections, confirming a dynamic and diverse leadership team that […]...

Scientists provide first evidence that the drug sildenafil may benefit patients with Leigh syndrome, and particularly those carrying mutations in the mitochondrial gene MT-ATP6....

Navigating the journey to gain a diagnosis of Primary Mitochondrial Myopathy can be unnecessarily long, intensely stressful, and fraught with obstacles....

The countdown is on to Rare Disease Day 2025 which takes place on 28 February....

IMP is proud to support MITGEST. This international consortium brings together world-class academic experts in mitochondrial research....

The SIMPATHIC project is preparing to launch a clinical trial using Sildenafil as a potential treatment for Leigh syndrome.  ...